Recent Expansions Charles River Laboratories International, Inc. has recently expanded its facilities in Somerville, Massachusetts, showcasing growth and potential for increased business collaborations and services in this emerging life sciences hub.
New Product Launches The launch of innovative products like Celsis Adapt Express and the introduction of the NCG mouse strains highlight Charles River's commitment to cutting-edge solutions, presenting opportunities for partnerships and sales within the biotechnology and pharmaceutical sectors.
Investment and Partnership Opportunities With investments from Confluence Investment Management LLC and a grant for developing New Approach Methodology, there are clear indicators of financial backing and collaborative projects, which could lead to potential sales engagements and strategic alliances.
Company Acquisition The recent acquisition of shares by Janney Montgomery Scott LLC signifies confidence in Charles River Laboratories International, Inc., potentially opening doors for new business relationships, client acquisitions, and service expansions.
Emerging Technological Innovations Charles River's tech stack, including platforms like Azure App Service and SAP Analytics Cloud, demonstrates a dedication to leveraging advanced technologies. This signals opportunities for tech-oriented sales partnerships and solutions tailored to the biotech and pharmaceutical industries.
Charles River Laboratories uses 8 technology products and services including Google Marketing Platform, Azure App Service, TrustArc, and more. Explore Charles River Laboratories's tech stack below.
| Charles River Laboratories Email Formats | Percentage |
| first.last@crl.com | 92% |
| last@crl.com | 3% |
| last.first@crl.com | 1% |
| first.middle@crl.com | 1% |
| flast@crl.com | 1% |
| filast@crl.com | 1% |
| first.middlelast@crl.com | 0% |
| first.l@crl.com | 1% |
| fir.last@crl.com | 0% |
| lf@crl.com | 0% |
| firstmiddle.last@crl.com | 0% |
| firstlast@crl.com | 0% |
| first@crl.com | 0% |
| flast@criver.com | 62% |
| first.last@criver.com | 34% |
| lfirst@criver.com | 3% |
| first@criver.com | 1% |
| flast@agiluxlabs.com | 72% |
| first_last@agiluxlabs.com | 10% |
| filast@agiluxlabs.com | 3% |
| first_l@agiluxlabs.com | 3% |
| firstl@agiluxlabs.com | 3% |
| first.l@agiluxlabs.com | 3% |
| first-last@agiluxlabs.com | 3% |
| last.first@agiluxlabs.com | 3% |
Biotechnology ResearchMassachusetts, United States10001+ Employees
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Company Overview
Media & News
Funding & FinancialsCharles River Laboratories has raised a total of $1.3M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2024.
Charles River Laboratories's revenue is in the range of $1B
Funding & FinancialsCharles River Laboratories has raised a total of $1.3M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2024.
Charles River Laboratories's revenue is in the range of $1B
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com